Clinical Trials in Tennessee

Showing 6301-6320 of 15,329 trials

Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps

NCT04728620

The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring \& preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate orders for the care. In addition, the investigators will assess pre-post change on secondary psychosocial outcomes (e.g., self-efficacy).

Diabetes Mellitus

Vanderbilt University Medical Center60 participantsStarted May 2021

Nashville, Tennessee, United States

COMPLETEDPhase 229 miles

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

The primary objective of this study is to evaluate the long-term safety and efficacy of UX007 in participants with LC-FAOD. The secondary objectives of this study are to evaluate the effect of UX007 on energy metabolism in LC-FAOD and evaluate the impact of UX007 on clinical events associated with LC-FAOD.

Carnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more

Ultragenyx Pharmaceutical Inc94 participantsStarted Dec 2014

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +8 more locations

Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Find Trials by Condition in Tennessee

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Evaluation of Rotation With a Multifocal Toric Contact Lens

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study